An observational study in Schizophrenia, sponsored by Sha'ar Menashe Mental Health Center. Status unknown. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2008-05-21.
Sponsored by Sha'ar Menashe Mental Health Center · Observational
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.
This study's planned enrollment of 15 is below the median of 178 across 491 observational studies indexed under Schizophrenia.
Browse Schizophrenia studies →Sha'ar Menashe Mental Health Center is the lead sponsor of 10 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).
Ages 18 -55 Men and/or women -
Exclusion Criteria:
Any subject suffering from inflammatory fever disease will be excluded from the study.
-
No study locations are listed for this record.
This study is status unknown, as verified in May 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sha'ar Menashe Mental Health Center